News

Endpoints News22h
In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
Axios on MSN13d
Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.
Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...
STAT5d
At gene therapy meeting, no one wants to talk about the Vinay Prasad (not) in the room
At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...
BioSpace1d
FDA’s New Risk-Based Approach to COVID-19 Vaccines Aims to Ease ‘Public Distrust’: Makary, Prasad
The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...
FDA sets new COVID booster guidelines requiring trials for approvals for healthy adults
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
STAT5d
Day 3 at ASGCT: Vinay Prasad speculation, screening newborns, promising data
A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...
Science-Based Medicine4dOpinion
I Am Calling on Dr. Vinay Prasad, the Medical Establishment, to Break His Silence on Vaccines as Measles And Pertussis Spread Under His Watch
For a brief period in 2022, Dr. Vinay Prasad faked a concern about routine vaccines to infect unvaccinated children with ...
Science-Based Medicine12dOpinion
Dr. Vinay Prasad is Now the Medical Establishment. It’s His Job to Run RCTs, and It’s Our Job to Call Him a Lying Piece of $#!& if He Fails.
From claiming COVID vaccines were perfect and would end the pandemic to treating rare, temporary vaccine side-effects, even ...
MedPage Today on MSN13dOpinion
Vinay Prasad Speaks to CBER Staff: Which Prasad Showed Up?
The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...
STAT2d
FDA will limit Covid vaccines to people over 65 or at high risk of serious illness, leaders say
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...
STAT3d
Some scientists are getting their NIH research dollars back
has quietly assumed influential roles at the FDA under Commissioner Marty Makary and CBER chief Vinay Prasad. As a political appointee advising on vaccines, she’s already participated in high ...